August 31, 2015 article Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases DOI: 10.1136/annrheumdis-2015-207776 OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 357 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics 2024 Immunity article Immunology and Microbiology T-cell and B-cell Immunology Open access 61 citations Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and gatekeeper features 2022 medRxiv preprint Immunology and Microbiology T-cell and B-cell Immunology Open access 3 citations T cell dysregulation in SLE 2022 Clinical Immunology article Medicine Systemic Lupus Erythematosus Research 76 citations Regulatory T cell function in autoimmune disease 2021 Journal of Translational Autoimmunity article Immunology and Microbiology T-cell and B-cell Immunology Open access 95 citations 4 results References 0